HF
TELA icon

HRT Financial’s TELA Bio TELA Stock Holding History

HRT Financial’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,229
Closed -$99K – 3124
2024
Q2 		$99K Buy
+21,229
New +$112K ﹤0.01% 1763
2023
Q2 		– Sell
-16,261
Closed -$173K – 3268
2023
Q1 		$173K Buy
+16,261
New +$179K ﹤0.01% 1953
2022
Q4 		– Sell
-13,768
Closed -$117K – 3136
2022
Q3 		$117K Buy
+13,768
New +$114K ﹤0.01% 2356
2021
Q4 		– Sell
-10,321
Closed -$140K – 4062
2021
Q3 		$140K Sell
10,321
-6,215
-38% -$86.7K ﹤0.01% 2802
2021
Q2 		$266K Buy
+16,536
New +$227K ﹤0.01% 2224

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HRT Financial's TELA Position: Q3 2024 in Review

HRT Financial sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 21,229 shares — an estimated $99K sold.

HRT Financial first reported a position in TELA in Q2 2021 and held it in 5 quarters. The position peaked at $266K in Q2 2021. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • HRT Financial reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 21,229 TELA Bio shares in Q3 2024, an estimated $99K.
  • HRT Financial first reported a position in TELA Bio in Q2 2021 and held it in 5 quarters.
  • HRT Financial's TELA Bio position peaked at $266K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.